Mackenzie Financial
TRIB

Mackenzie Financial’s Trinity Biotech TRIB Stock Holding History

Mackenzie Financial’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,878
Closed -$73K – 1286
2021
Q1 		$73K Sell
3,878
-342
-8% -$8.22K ﹤0.01% 1100
2020
Q4 		$80K Buy
+4,220
New +$69.8K ﹤0.01% 1014

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Mackenzie Financial's TRIB Position: Q2 2021 in Review

Mackenzie Financial sold out of Trinity Biotech (TRIB) in Q2 2021, closing a stake of 3,878 shares — an estimated $73K sold.

Mackenzie Financial first reported a position in TRIB in Q4 2020 and held it in 2 quarters. The position peaked at $80K in Q4 2020. 29 funds tracked by Wall St. Rank hold TRIB as of Q2 2021.

  • Mackenzie Financial reported no remaining Trinity Biotech position as of Q2 2021 after selling out during the quarter.
  • Mackenzie Financial sold 3,878 Trinity Biotech shares in Q2 2021, an estimated $73K.
  • Mackenzie Financial first reported a position in Trinity Biotech in Q4 2020 and held it in 2 quarters.
  • Mackenzie Financial's Trinity Biotech position peaked at $80K in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2021.

Based on Mackenzie Financial's 13F filing for Q2 2021, filed 11 Aug 2021.